Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models

Cancer Gene Therapy

Volumn 7, Issue 1, 2000, Pages 13-19

  Staba, Mary Jane ^a   Wickham, Thomas J ^b   Kovesdi, Imre ^b   Hallahan, Dennis E ^c,d  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b GENVEC INC   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Adenovirus; Fiber; Gene therapy; Gliomas

Indexed keywords

BETA GALACTOSIDASE; CELL SURFACE RECEPTOR; COAT PROTEIN; HEPARAN SULFATE; INTEGRIN RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA TRANSFER; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REPORTER GENE; STRAIN DIFFERENCE; VIRUS CELL INTERACTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; RODENTIA;

EID: 0033961964     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700104     Document Type: Article

References (21)

1. Mahaley MS. Neuro-oncology index and review (adult primary brain tumors): radiotherapy, chemotherapy, immunotherapy, photodynamic therapy. J Neurooncol. 1991; 11:85-147.
2. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71:2585-2597.
3. Chen SH, Shine HD, Goodman JC. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA. 1994;91:3054-3057.
4. Perez-Cruet MJ, Trask TW, Chen SH, et al. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res. 1994;39:506-511.
5. Boviatsis EJ, Chase M, Wei MX, et al. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther. 1995;5:183-191.
6. Eck SL, Alavi JB, Alavi A, et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther. 1996;7: 1465-1482.
7. McGrory WJ, Bautista G, Graham T. A simple technique for the rescue of early region I mutations into adenovirus type 5. Virology. 1988;163:614-617.
8. Jones N, Shenk T. Isolation of Ad5 mutants defective for transformation. Cell. 1979;17:683-689.
9. Wickham TJ, Tzeng E, Shears LL II, et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol. 1997;71:8221-8229.
10. Wickham TJ, Segal DM, Roelvink ME, et al. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol. 1996;70: 6831-6838.
11. Russi TJ, Hirschowitz C, Crystal RG. Delayed-type hypersensitivity response to high doses of adenoviral vectors. Hum Gem Ther. 1997;8:323-330.
12. Douglas JT, Curiel DT. Adenoviruses as vectors for gene therapy. Sci Med. 1997;1:44-53.
13. Wickham TJ, Roelvink PW, Brough DE, et al. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol. 1996;14:1570-1573.
14. 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
15. Wickham TJ, Carrion ME, Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 1995;2:750-756.
16. Bondi A, Chieregatti G, Eusebi V. The use of β-galactosidase as a tracer in immunocytochemistry. Histochemistry. 1982;76:153-158.
17. Le Gal La Salle G, Robert JJ, Bernard S, et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 1993;259:988-990.
18. Curiel DT, Wagner EM, Cotten M, et al. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Hum Gene Ther. 1992;3:147-154.
19. Fromm JR, Helman RE, Caldwell EE, et al. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys. 1995;323:279-287.
20. Peltekian E, Parrish E, Bouchard C, et al. Adenovirus-mediated gene transfer to the brain: methodological assessment. J Neurosci Methods. 1997;71:77-84.
21. Muldoon LL, Nilaver G, Kroll RA, et al. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am J Pathol. 1995;147: 1840-1851.